DUBLIN, Feb. 7, 2024 /PRNewswire/ — The “Veterinary Dermatology Drugs Global Market Report 2024” has been added to ResearchAndMarkets.com’s offering. The global veterinary dermatology drugs market is experiencing a robust growth trajectory, according to a comprehensive new study. Industry analysis indicates a projected rise from $7.75 billion in 2023 to $8.67 billion in 2024, advancing at… Continue reading Veterinary Dermatology Drugs Market Set to Surge with Strong CAGR by 2024, Insights on Emerging Trends
Category: Newswire
Envision Energy Featured Once Again in WEF Report for ESG Excellence
The World Economic Forum Recognizes Envision Energy for its Pioneering Sustainability Efforts in the Ordos Net Zero Industrial Park. GENEVA, Feb. 7, 2024 /PRNewswire/ — The World Economic Forum (WEF) has unveiled its “World Transitioning Industrial Clusters Annual Report”, highlighting the remarkable achievements of industrial clusters worldwide in their journey towards sustainability. Among them, the Ordos… Continue reading Envision Energy Featured Once Again in WEF Report for ESG Excellence
First in Human Dosed in Clinical Trial of ZMA001 for Treatment of Pulmonary Arterial Hypertension (PAH)
INCHEON, South Korea, Feb. 7, 2024 /PRNewswire/ — Zymedi announced today that the first in human dosage of ZMA001, a monoclonal antibody being developed as a first-in-class treatment for Pulmonary Arterial Hypertension (PAH) has been initiated. The placebo-controlled phase 1 trial designed to ascertain the safety and dosage of ZMA001 is a collaborative effort between Zymedi… Continue reading First in Human Dosed in Clinical Trial of ZMA001 for Treatment of Pulmonary Arterial Hypertension (PAH)
FILING DEADLINE–Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Inspire Medical Systems, Inc. – INSP
CEDARHURST, N.Y., Feb. 7, 2024 /PRNewswire/ — The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Inspire Medical Systems, Inc. (NYSE: INSP), if they purchased the Company’s shares between May 3, 2023 and November 7, 2023, inclusive (the “Class Period”). Shareholders have until February 20, 2024 to file lead… Continue reading FILING DEADLINE–Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Inspire Medical Systems, Inc. – INSP
FILING DEADLINE–Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Driven Brands Holdings Inc. – DRVN
CEDARHURST, N.Y., Feb. 7, 2024 /PRNewswire/ — The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Driven Brands Holdings Inc. (NasdaqGS: DRVN), if they purchased the Company’s shares between October 27, 2021, and August 1, 2023, inclusive (the “Class Period”). Shareholders have until February 20, 2024 to file lead plaintiff… Continue reading FILING DEADLINE–Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Driven Brands Holdings Inc. – DRVN
FILING DEADLINE–Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Focus Financial Partners Inc. – FOCS
CEDARHURST, N.Y., Feb. 7, 2024 /PRNewswire/ — The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Focus Financial Partners Inc. (NasdaqGS: FOCS), if they (1) sold shares of Focus Financial common stock from February 27, 2023 through the closing of the “take-private” acquisition of Focus Financial by Clayton, Dubilier &… Continue reading FILING DEADLINE–Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Focus Financial Partners Inc. – FOCS
FILING DEADLINE–Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Dada Nexus Limited – DADA
CEDARHURST, N.Y., Feb. 7, 2024 /PRNewswire/ — The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Dada Nexus Limited (NasdaqGS: DADA), if they purchased or otherwise acquired the Company’s securities between May 11, 2023 and January 8, 2024, inclusive (the “Class Period”). Shareholders have until March 11, 2024 to… Continue reading FILING DEADLINE–Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Dada Nexus Limited – DADA
FILING DEADLINE–Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of British American Tobacco p.l.c – BTI
CEDARHURST, N.Y., Feb. 7, 2024 /PRNewswire/ — The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of British American Tobacco p.l.c (“BA Tobacco” or the “Company”) (NYSE: BTI), if they purchased or otherwise acquired the Company’s securities between February 9, 2023 and December 6, 2023, inclusive (the “Class Period”). Shareholders have… Continue reading FILING DEADLINE–Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of British American Tobacco p.l.c – BTI
FILING DEADLINE–Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Archer-Daniels-Midland Company – ADM
CEDARHURST, N.Y., Feb. 7, 2024 /PRNewswire/ — The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Archer-Daniels-Midland Company (“ADM” or the “Company”) (NYSE: ADM), if they purchased the Company’s securities between April 30, 2020 and January 22, 2024, inclusive (the “Class Period”). Shareholders have until March 25, 2024 to… Continue reading FILING DEADLINE–Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Archer-Daniels-Midland Company – ADM
FILING DEADLINE–Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of New York Community Bancorp, Inc. – NYCB
CEDARHURST, N.Y., Feb. 7, 2024 /PRNewswire/ — The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of New York Community Bancorp, Inc. (“NYCB” or the “Company”) (NYSE: NYCB), if they purchased the Company’s securities between March 1, 2023 and January 30, 2024, inclusive (the “Class Period”). Shareholders have until April 8,… Continue reading FILING DEADLINE–Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of New York Community Bancorp, Inc. – NYCB